Development of Inhibitors of the IGF-IR/PI3K/Akt/mTOR Pathway

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|5|3|189-208

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.5, Iss.3, 2010-09, pp. : 189-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunohistochemical and molecular analysis of PI3K/AKT/mTOR pathway in esophageal carcinoma

By  

APMIS (ELECTRONIC), Vol. 123, Iss. 8, 2015-08 ,pp. : 639-647

John Wiley & Sons Inc

Access to resources Recommend Favorite

The PI3K/AKT/mTOR pathway is involved in direct apoptosis of CLL cells induced by ROR1 monoclonal antibodies

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 3, 2015-05 ,pp. : 455-458

John Wiley & Sons Inc

Access to resources Recommend Favorite

miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway

By            

International Journal of Molecular Medicine, Vol. 35, Iss. 5, 2015-01 ,pp. : 1301-1308

Spandidos Publications

Access to resources Recommend Favorite

Puquitinib mesylate (XC-302) induces autophagy via inhibiting the PI3K/AKT/mTOR signaling pathway in nasopharyngeal cancer cells

By          

International Journal of Molecular Medicine, Vol. 36, Iss. 6, 2015-01 ,pp. : 1556-1562

Spandidos Publications

Access to resources Recommend Favorite

GOLM1 promotes prostate cancer progression through activating PI3K‐AKT‐mTOR signaling

By  

THE PROSTATE, Vol. 78, Iss. 3, 2018-02 ,pp. : 166-177

John Wiley & Sons Inc

Access to resources Recommend Favorite